Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: Cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 1, 2010, Pages 20-27

  Valderrey, Andrea D ^a   Pozuelo, María José ^b   Jiménez, Pedro A ^b   Maciá, María D ^c   Oliver, Antonio ^c   Rotger, Rafael ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Bronchiectasis, chronic obstructive pulmonary disease; Cystic fibrosis; FpvA; MucA; PFGE; Pseudomonas aeruginosa

Indexed keywords

BACTERIAL PROTEIN; PROTEIN FPVA; PROTEIN MUCA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENETIC ANALYSIS; GENOTYPE; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

EID: 77955789212     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.04.008     Document Type: Article

References (38)

1. Anthony M., Rose B., Pegler M.B., Elkins M., Service H., Thamotharampillai K., Watson J., Robinson M., Bye P., Merlino J., Harbour C. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol. 2002, 40:2772-2778.
2. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr. Opin. Pulm. Med. 2008, 14:595-599.
3. Bodilis J., Ghysels B., Osayande J., Matthijs S., Pirnay J.P., Denayer J., De Vos D., Cornelis P. Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ. Microbiol. 2009, 11:2123-2135.
4. Bragonzi A., Wiehlmann L., Klockgether J., Cramer N., Worlitzsch D., Doring G., Tummler B. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 2006, 152:3261-3269.
5. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., Calverley P.M.A., Chavannes N., Dillard T., Fahy B., Fein A., Heffner J., Lareau S., Meek P., Martinez F., McNicholas W., Muris J., Austegard E., Pauwels R., Rennard S., Rossi A., Siafakas N., Tiep B., Vestbo J., Wouters E., ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004, 23:932-946.
6. Cezairliyan B.O., Sauer R.T. Control of Pseudomonas aeruginosa AlgW protease cleavage of MucA by peptide signals and MucB. Mol. Microbiol. 2009, 72:368-379.
7. Ciofu O., Lee B., Johannesson M., Hermansen N.O., Meyer P., Hoiby N., the Scandinavian Cystic Fibrosis Study Consortium Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 2008, 154:103-113.
8. Davies G., Wells A.U., Doffman S., Watanabe S., Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur. Respir. J. 2006, 28:974-979.
9. de Chial M., Ghysels B., Beatson S.A., Geoffroy V., Meyer J.M., Pattery T., Baysse C., Chablain P., Parsons Y.N., Winstanley C., Cordwell S.J., Cornelis P. Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology 2003, 149:821-831.
10. De Vos D., De Chial M., Cochez C., Jansen S., Tümmler B., Meyer J., Cornelis P. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch. Microbiol. 2001, 175:384-388.
11. Deretic V., Martin D.W., Schurr M.J., Mudd M.H., Hibler N.S., Curcic R., Boucher J.C. Conversion to mucoidy in Pseudomonas aeruginosa. Biotechnology 1993, 11:1133-1136.
12. Deretic V., Schurr M.J., Yu H. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol. 1995, 3:351-356.
13. Govan J.R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Mol. Biol. Rev. 1996, 60:539-574.
14. Hogardt M., Hoboth C., Schmoldt S., Henke C., Bader L., Heesemann J. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 2007, 195:70-80.
15. Jelsbak L., Johansen H.K., Frost A.L., Thogersen R., Thomsen L.E., Ciofu O., Yang L., Haagensen J.A.J., Hoiby N., Molin S. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 2007, 75:2214-2224.
16. Josselin B., Bart G., Julie O., Sandra M., Jean-Paul P., Sarah D., Daniel D.V., Pierre C. Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ. Microbiol. 2009, 11:2123-2135.
17. King P.T., Holdsworth S.R., Freezer N.J., Villanueva E., Holmes P.W. Microbiologic follow-up study in adult bronchiectasis. Respir. Med. 2007, 101:1633-1638.
18. Loebinger M.R., Wells A.U., Hansell D.M., Chinyanganya N., Devaraj A., Meister M., Wilson R. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur. Respir. J. 2009, 34:843-849.
19. Lyczak J.B., Cannon C.L., Pier G.B. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 2002, 15:194-222.
20. Macia M.D., Blanquer D., Togores B., Sauleda J., Perez J.L., Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 2005, 49:3382-3386.
21. Martin D.W., Schurr M.J., Mudd M.H., Govan J.R., Holloway B.W., Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8377-8381.
22. Martinez-Garcia M.A., Soler-Cataluna J.J., Perpina-Tordera M., Roman-Sanchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
23. Martinez-Solano L., Macia M.D., Fajardo A., Oliver A., Martinez J.L. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin. Infect. Dis. 2008, 47:1526-1533.
24. Mossialos D., Amoutzias G.D. Role of siderophores in cystic fibrosis pathogenesis: foes or friends?. Int. J. Med. Microbiol. 2009, 299:87-98.
25. Murphy T.F. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2009, 15:138-142.
26. Murphy T.F., Brauer A.L., Eschberger K., Lobbins P., Grove L., Cai X., Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 177:853-860.
27. Murray M.P., Turnbull K., Macquarrie S., Hill A.T. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur. Respir. J. 2009, 33:312-318.
28. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
29. Pela R., Marchesani F., Agostinelli C., Staccioli D., Cecarini L., Bassotti C., Sanguinetti C.M. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch. Chest Dis. 1998, 53:262-267.
30. Reiling S.A., Jansen J.A., Henley B.J., Singh S., Chattin C., Chandler M., Rowen D.W. Prc protease promotes mucoidy in mucA mutants of Pseudomonas aeruginosa. Microbiology 2005, 151:2251-2261.
31. Rowen D.W., Deretic V. Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Mol. Microbiol. 2000, 36:314-327.
32. Saiman L. Microbiology of early CF lung disease. Paediatr. Respir. Rev. 2004, 5:S367-S369.
33. Sethi S., Evans N., Grant J.B., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 2002, 347:465-471.
34. Smith E.E., Sims E.H., Spencer D.H., Kaul R., Olson M.V. Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J. Bacteriol. 2005, 187:2138-2147.
35. Soler N., Torres A., Ewig S., Gonzalez J., Celis R., El Ebiary M., Hernandez C., Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am. J. Respir. Crit. Care Med. 1998, 157:1498-1505.
36. Spencer D.H., Kas A., Smith E.E., Raymond C.K., Sims E.H., Hastings M., Burns J.L., Kaul R., Olson M.V. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 2003, 185:1316-1325.
37. Wiehlmann L., Wagner G., Cramer N., Siebert B., Gudowius P., Morales G., Köhler T., van Delden C., Weinel C., Slickers P., Tümmler B. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8101-8106.
38. Zoumot Z., Wilson R. Respiratory infection in noncystic fibrosis bronchiectasis. Curr. Opin. Infect. Dis. 2010, 23:165-170.